Regular Market Approval
- All
- News
-
Banks Wrote Off Bad Loans Worth Over 10 Lakh Crore In Last 5 Financial Years: Minister
- Tuesday December 13, 2022
- Business | Press Trust of India
"Banks write off NPAs as part of their regular exercise to clean up their balance sheet, avail tax benefit and optimise capital, in accordance with RBI guidelines and policy approved by their boards," Nirmala Sitharaman said.
- www.ndtv.com/business
-
Covid Vaccines Covishield, Covaxin Get Conditional Market Approval: Report
- Thursday January 27, 2022
- India News | Press Trust of India
India's drug regulator has granted regular market approval for COVID-19 vaccines Covishield and Covaxin for use in the adult population subject to certain conditions, Health Minister Mansukh Mandaviya said today.
- www.ndtv.com
-
Covishield, Covaxin Cleared For Market Approval By Expert Panel
- Wednesday January 19, 2022
- India News | Press Trust of India
An expert panel of India's central drug authority today recommended granting regular market approval to Covishield and Covaxin, which are currently only authorised for emergency use in the country, subject to certain conditions, official sources said
- www.ndtv.com
-
Banks Wrote Off Bad Loans Worth Over 10 Lakh Crore In Last 5 Financial Years: Minister
- Tuesday December 13, 2022
- Business | Press Trust of India
"Banks write off NPAs as part of their regular exercise to clean up their balance sheet, avail tax benefit and optimise capital, in accordance with RBI guidelines and policy approved by their boards," Nirmala Sitharaman said.
- www.ndtv.com/business
-
Covid Vaccines Covishield, Covaxin Get Conditional Market Approval: Report
- Thursday January 27, 2022
- India News | Press Trust of India
India's drug regulator has granted regular market approval for COVID-19 vaccines Covishield and Covaxin for use in the adult population subject to certain conditions, Health Minister Mansukh Mandaviya said today.
- www.ndtv.com
-
Covishield, Covaxin Cleared For Market Approval By Expert Panel
- Wednesday January 19, 2022
- India News | Press Trust of India
An expert panel of India's central drug authority today recommended granting regular market approval to Covishield and Covaxin, which are currently only authorised for emergency use in the country, subject to certain conditions, official sources said
- www.ndtv.com